Prognosis analyses according to outcome: hepatocellular carcinoma (HCC), death after hepatocellular carcinoma, and death unrelated to hepatocellular carcinoma
| HCC (60 events) | Death after HCC (34 events) | Death unrelated to HCC (48 events) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HR | (95 CI) | p Value | HR | (95 CI) | p Value | HR | (95 CI) | p Value | |||
| Age | 1.05 | (1.02–1.08) | 0.0005 | 1.03 | (0.98–1.08) | 0.23 | 1.04 | (1.01–1.07) | 0.014 | ||
| Female | 0.47 | (0.26–0.85) | 0.013 | 0.96 | (0.38–2.40) | 0.93 | 1.12 | (0.61–2.09) | 0.71 | ||
| Oesophaeal varices2-150 | 2.36 | (1.25–4.45) | 0.008 | 0.63 | (0.26–1.53) | 0.30 | 2.75 | (1.48–5.10) | 0.0013 | ||
| Platelets | 0.99 | (0.98–0.99) | 0.029 | 1.002 | (0.99–1.01) | 0.61 | 0.99 | (0.98–0.99) | 0.006 | ||
| Bilirubin | 1.01 | (1.005–1.02) | 0.003 | 1.000 | (0.99–1.01) | 0.98 | 1.003 | (0.99–1.01) | 0.61 | ||
| Alcohol > 40 g | 0.56 | (0.26–1.23) | 0.15 | 0.45 | (0.14–1.46) | 0.18 | 0.94 | (0.41–2.17) | 0.89 | ||
| Tobacco | 1.01 | (0.99–1.02) | 0.42 | 1.04 | (1.02–1.06) | 0.0006 | 1.005 | (0.99–1.02) | 0.56 | ||
| Albumin | 1.03 | (0.97–1.09) | 0.36 | 0.93 | (0.86–1.01) | 0.07 | 0.90 | (0.86–0.95) | 0.0001 | ||
↵2-150 Grade 2 or >2.
HR, hazard ratio; 95 CI, 95% confidence interval.